Community Research and Development Information Service - CORDIS

  • European Commission
  • Projects and Results
  • Periodic Report Summary 2 - ERANID (European Research Area Network on Illicit Drugs - Towards integrated European research in illicit drugs: cause and nature of drug problems; interventions and policies)

ERANID Report Summary

Project ID: 321580
Funded under: FP7-SSH
Country: Netherlands

Periodic Report Summary 2 - ERANID (European Research Area Network on Illicit Drugs - Towards integrated European research in illicit drugs: cause and nature of drug problems; interventions and policies)

Project Context and Objectives:
ERANID, the European Research Area Network on Illicit Drugs- Towards integrated European research in illicit drugs: cause and nature of drugproblems; interventions and policies, is funded by the 7th Framework Programme of the European Commission (Grant Agreement 321580). ERANID brings together 11 funding bodies from 6 countries (Belgium, France, Italy, Portugal, The Netherlands and the United Kingdom with the support of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Pompidou Group of the Council of Europe and 11 funding agencies within and outside Europe as associate partners. Information on ERANID can be found at the website: ww,

Project context and objectives.
ERANID will promote multidisciplinary and cross-national innovative research activities with added value on a European level and with an open eye to worldwide development. The core element of the research to be granted will be social sciences and humanities, with the aim to improve understanding of the cause and nature of drug problems and how these develop in society. Also the analysis of trends and developments and the promotion of effective policy responses based on new knowledge belong to the scope of ERANID.

The general objectives are the following:
- Stimulating cross border research cooperation in demand and supply issues on specific prioriteis topics selected by the participating countries.
- Supporting political commitment on member State level to work together in funding joint drug research of EU member States.
- Creating a shared understanding between the ERANID beneficiaries of the research priorities to support the implementation of the EU Drugs Action Plan 2009-2012 and byond.
- Improving the access to research and research findings in EU member States.
- Facilitating the interaction between the priority-setting of national funding programmes and EU funding programmes.
- Stimulating research relevant for the development of well founded drug policy decisions.

ERANID will form a platform for researcher and policymakers.

Key objectives for the second reporting period
- The development and writing of the Strategic Research Agenda.
- The launch of the first joint call.
- The development of a social community for researchers and stakeholders.
Project Results:
Main achievement in 2014 is the writing of the Strategic Research Agenda (SRA). There was quite some delay in the writing of the SRA due to the delays in the execution of task 3.1 and the agreement on the content of the SRA. Late in the process it was decided that the questionnaire that had been developed had to be replaced, therefore the gathering of the data took longer than foreseen. November 2014 there was an agreement on the content of the SRA. December 2014 the SRA was presented in Brussels in a meeting of the HDG. In 2015 the main aim of the MG and NSC was the execution of two calls during the ERANID project period. The NSC gave it's approval to the planning of two joint calls: September 2015 and May 2016. Condition for the realisation of this goal was the availability of a digital submission system. The leader of Work Package 5 ( implementing the research calls) and the Coordinator proposed to the NSC to use the digital facilities of ZonMw, the NSC gave it's consent after which a cooperation agreement between SICAD and ZonMw was drawn up and signed. The call was launched September 15 2015 and presented in Lisbon on the Lisbon addiction conference September 22nd 2015. November 24th was the deadline for applicants to submit a proposal. ERANID received 30 proposals of which 29 passed the national eligibility check. Accordingly to the Governance of the Call and the Guidelines for Reviewers, the proposals were sent to experts for a scientific review. Poland, Germany and Sweden participated in the first joint call.
April 2015 discussions were held on the withdrawal of the French partners: Inserm, OFDT and CNRS and the future partnership of MILDECA. Mrs. Florence Lafay-Dufour participates since May 2015. Mildeca stands for Mission Interministerielle de Lutte contre les Drogues et les Conduites Addictive. To increase the publicity for the ERANID project a social community has been developed on the website of ERANID. Here researchers and stakeholders can find a platform for discussions, find out about expertise and fields of research interests.

Potential Impact:
The Peer Review Panel and the funders meeting are scheduled for March 2016. The second joint call will be launched in the end of May are the beginning of June 2016. Aim of the ERANID partners is to establish a solid network of researchers and funding organisations in different member States that will contribute in the development of research methodology and is of special importance for the evaluation of policies and programmes. A closer collaboration will add to a shared understanding of and consensus on methodological issues. Cross border collaboration gives the opportunity to compare differences in policy frameworks and implementation strategies and therefore a better understanding of the impact of the measures taken.
List of Websites:

Reported by

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top